International Flavors & Fragrances Inc. (IFF) is in view for a number of reasons including investment moves, earnings calls, and strategic business developments. UBS continues to hold a neutral rating with a PT of $83, while Handelsbanken Fonder AB maintains a stock holding valued at $8.29 million. IFF recently appointed Virginia Drosos to its board and announced a regular payout of $0.40 dividend. In addition, the significant move of shaking up its flavors and fragrances mix is in its consideration. Expansion projects are visible in Cedar Rapids ingredients facilities with ground-breaking ceremonies. They have introduced a new approach - 'Science of Performance' to perfume design that might leverage real-time consumer feedback with AI. Uncertainty lies in the stock as analysts have a moderate buy recommendation and a bearish sentiment exists with the EPS missing expectations in Q1 2025 earnings. Insiders' purchase of shares counters the mixed sentiments, signaling a possible turnaround for the company. Growth prospects lie in IFF's investments in Shanghai and Dubai Creative Centers as they reach out to new markets. IFF is expanding its portfolio with advanced science-driven solutions meant for pets and innovating in the beauty industry with Xelestia. A significant development is the completion of the Pharma Solutions Business sale, paving the path for focused growth.
International Flavors Fragrances IFF News Analytics from Thu, 07 Nov 2024 08:00:00 GMT to Sat, 14 Jun 2025 11:53:39 GMT -
Rating 2
- Innovation 5
- Information 7
- Rumor -3
